ArticleExperimental and therapeutic medicine2020

miR-187-3p increases gemcitabine sensitivity in breast cancer cells by targeting FGF9 expression.

Yingqi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.